Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-20-007058

Options or other derivatives

  • Director acquired 13,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Saad Mark E Director 2020-06-05 Grant or award · Stock Option (Right to Buy) +13,000 13,000 D
Loading xslF345X03/edgar.xml…